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Mild traumatic brain injury (mTBI, also referred to as concussion) accounts for the major-
ity of all traumatic brain injuries. The consequences of repetitive mTBI have become of
particular concern for individuals engaged in certain sports or in military operations. Many
mTBI patients suffer long-lasting neurobehavioral impairments. In order to expedite pre-
clinical research and therapy development, there is a need for animal models that reflect
the long-term cognitive and pathological features seen in patients. In the present study, we
developed and characterized a mouse model of repetitive mTBI, induced onto the closed
head over the left frontal hemisphere with an electromagnetic stereotaxic impact device.
Using GFAP-luciferase bioluminescence reporter mice that provide a readout of astrocyte
activation, we observed an increase in bioluminescence relative to the force delivered
by the impactor after single impact and cumulative effects of repetitive mTBI. Using the
injury parameters established in the reporter mice, we induced a repetitive mTBI in wild-
type C57BL/6J mice and characterized the long-term outcome. Animals received repetitive
mTBI showed a significant impairment in spatial learning and memory when tested at 2
and 6 months after injury. A robust astrogliosis and increased p-Tau immunoreactivity were
observed upon post-mortem pathological examinations.These findings are consistent with
the deficits and pathology associated with mTBI in humans and support the use of this
model to evaluate potential therapeutic approaches.
Keywords: mild traumatic brain injury, long-term, neurobehavior, bioluminescence, astrogliosis
INTRODUCTION
Traumatic brain injury (TBI) is a major global health concern,
and the CDC has estimated that over 1.5 million people experi-
ence a TBI each year in the US. Clinically, mild traumatic brain
injury (mTBI, also referred to as concussion) accounts for approx-
imately 80% of all TBIs, the majority of which result from closed
head, concussive impact injuries (1). In military populations,
mTBI caused by non-blast concussive impact and/or primary blast
events has become the signature injury in the conflicts in Iraq and
Afghanistan (2), with an estimated 12–35% of soldiers experi-
encing a mTBI during their deployment (3). While most mTBI
patients recover without significant long-term consequences, 7–
30% (even up to 60% in some reports) of individuals are estimated
to suffer from a post-concussive syndrome that comprises physi-
cal, cognitive, and emotional symptoms (4, 5). These long-lasting
symptoms include memory impairments, difficulty in concentra-
tion, depression, apathy, and anxiety (4, 5). Because these symp-
toms are usually observed in the absence of significant structural
damage, patients sustaining mTBI are difficult to diagnose (6), and
routine clinical and laboratory evaluations of mTBI patients often
fail to show clear morphological brain defects.
Recently, the consequences of repetitive mTBI from multiple
concussions have become of particular concern for individuals
engaged in certain sports or in military operations because they
are at high risk of repeated concussion (7, 8). Military personnel
often have several mTBI exposures over the course of their lives and
possibly within single deployments (9, 10). Epidemiological stud-
ies revealed that about 60% of retired professional football players
sustained at least one concussion during their careers and approx-
imately 25% experienced repeated injuries (11). Recurrent brain
injuries, even when mild, may interfere with neuropsychological
recovery (9, 12). Therefore, repetitive mTBI has been associated
with greater severity of symptoms, with longer recovery time, and
with earlier onset of age-related memory deficits and dementia
(13). Repeated concussions have also been associated with chronic
traumatic encephalopathy (CTE), a neurodegenerative disorder
with progressive impairments of memory and cognition, as well
as depression, anxiety, and motor abnormalities (14–16).
Our understanding of the mechanisms of these behavioral
deficits is still largely incomplete. Animal models would certainly
facilitate a better understanding of the pathological and behav-
ioral outcomes as a result of concussion (17–19). Therefore, there
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has been a recent focus in developing animal models of mTBI.
A large number of animal models of mTBI have been developed
and they have been effective in characterizing the pathological and
behavioral changes after acute (i.e., single impact) mTBI. Current
animal models of concussion have included mild to moderate ver-
sions of fluid-percussion impact (FPI), controlled cortical impact
(CCI), and weight drop injury (20, 21). Although these mod-
els have demonstrated mild to moderate injury severity levels,
most are not capable of mimicking true closed-head concussive
injury. Furthermore, most of the current mTBI models have been
reported to produce some degree of immediate or short-term
behavioral deficits; however, it is not clear whether these deficits
are long-lasting since few of the published studies made long-term
observations beyond 1 month (17, 18). Therefore, our goal of this
study was to develop a clinically relevant closed-head injury of
repetitive mTBI that results in long-term behavioral and patholog-
ical alterations modeling mild brain injury in humans. To establish
injury parameters, we first employed bioluminescence imaging in
reporter mice expressing luciferase under the control of a GFAP
promoter (GFAP-luc mice) (22, 23). Bioluminescence imaging of
GFAP-luc mice enables us to test a relatively large number of
injury conditions in a medium-throughput manner by follow-
ing astrogliosis and neural injury in the same mice throughout
the course of injury. We then implemented the injury parameters
established in the reporter mice and induced a repetitive mTBI in
wild-type C57BL/6J mice. To further validate the long-term cog-
nitive and pathological effects of the injury model, we performed
behavioral testing and post-mortem pathological examinations of
brain tissue.
MATERIALS AND METHODS
ANIMALS
The experiments were approved by the Institutional Animal Care
and Use Committee of VA Palo Alto Health Care System, and
were in accordance with the National Institutes of Health Guide
for the Care and Use of Laboratory Animals. Two mouse lines
were used: bioluminescence reporter mice expressing luciferase
under the control of a GFAP promoter (GFAP-luc mice, FVB/N
background) (Caliper Life Science, now part of Caliper Life Sci-
ence, Hopkinton, MA, USA) (22, 23) and wild-type C57BL/6J mice
(The Jackson’s Laboratory, Bar Harbor, ME, USA). Bedding, nest-
ing material, food, and water were provided ad libitum. Ambient
temperature was controlled at 20–22°C with 12-h light/12-h dark
cycles. Mice were 2–3 months of age at the beginning of experi-
ments. All behavioral testing was performed in isolated behavior
rooms.
A MOUSE MODEL OF REPETITIVE CLOSED-HEAD mTBI
Closed-head injury was induced using a Benchmark Stereotaxic
Impactor (MyNeurolab, St. Louis, MO, USA) with modifications.
The Benchmark Stereotaxic Impactor is an electromagnetic stereo-
taxic impact device capable of producing consistent, graded CCI
injuries in adult mice with stereotaxic control of impact location
and depth at high velocities (24). Recently it was modified to pro-
duce repetitive closed-skull TBI in mice (25). We mounted an
actuator on a stereotaxic frame (David Kopf Instruments, Tujunga,
CA, USA) at a 40° angle (Figure 1A, left panel). A rubber tip (25) or
self-adhesive bumper (3M, St. Paul, MN, USA) was mounted onto
a customized impact probe tip (9 mm in diameter). Mice were
anesthetized with isoflurane (2.5% induction, 1.0% maintenance)
and the scalp was shaved. Mice were placed in the stereotaxic frame
and secured in prone position in a customized foam mold, with
isoflurane delivered by a gas anesthesia mask (Stoelting, Wood
Dale, IL, USA) (Figure 1A, left panel). An ear bar (with the non-
pointed end touching the skin) (Stoelting, Wood Dale, IL, USA)
was used to assist to position the head. The probe tip was fully
extended and lowered until the vertex of the bumper touched the
scalp (Figure 1A, middle panel). The stereotaxic manipulator was
adjusted so that the vertex of the bumper impacted the scalp at a
consistent point in relation to the eye and ear of injury side of the
head (Figure 1A, right panel). The center of impact corresponds to
the following coordinates: from Bregma: AP 1.2 mm (1.2 mm ante-
rior to the bregma), ML 4.2 mm (4.2 mm lateral to the midline),
according to the mouse brain atlas (26). To induce an impact, the
tip was retracted automatically. The ear bar was gently removed to
allow the head to move with little or no restraint upon impact. The
stereotaxic device was then moved down, and the electromagnetic
device was triggered, driving the tip into the head at a speed and a
dwell time set from the electronics control box. The size and shape
of the probe tip and bumper, the distance that stereotaxic device
is moved down (impact depth), the speed the probe tip travels
(impact speed), and the dwell time can be varied to achieve con-
cussions of different severities. In addition, the location and the
angle at which the probe tip impacted the head (impact location
and angle) can be adjusted through the stereotaxic manipulator.
After impact, the mice were allowed to recover from anesthesia
on a warming pad and then returned to their home cages. For
repetitive injuries, identical impact procedures were performed at
an interval of 24± 1 h. For sham injuries, the same procedure was
performed except that the impact device was discharged in the air;
the handling of the mice and duration of anesthesia were identical
for both mTBI and sham procedures (24, 25).
In this study, we chose to vary impact speeds (3–5 m/s) for
the injury phase while keeping other parameters (impact depth:
3 mm; dwell time: 0.2 s; impact probe tip: 9 mm; and impact
angle: 40°) consistent. Similar parameters have been used to induce
mTBI in CCI or closed-skull concussions (24, 25). A total of 106
mice (included both lines) were used in this study. There were
no immediate fatalities with these settings. Subcutaneous hem-
orrhages were observed in GFAP-luc mice impacted with 5 m/s
of impact speed (10%) and with repetitive impacts (25%). These
mice with excluded from behavioral and pathological analyses.
Subcutaneous hemorrhages or skull fractures were not observed
in C57BL/6J mice after three impacts of repetitive injury at 4 m/s.
IN VIVO BIOLUMINESCENCE IMAGING
Bioluminescence emitted from the brain of GFAP-luc mice was
detected with the In vivo Imaging System (IVIS Spectrum; Caliper
Life Science, Alameda, CA, USA) as previously described (22, 27,
28). Briefly, mice were injected intraperitoneally with 150 mg/kg
d-luciferin 10 min before imaging and anesthetized with isoflu-
rane during imaging. Photons emitted from living mice were
acquired as photons per second per square centimeter per stera-
dian using LIVINGIMAGE software (version 4.0) and integrated
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FIGURE 1 | A mouse model of closed-head mTBI using an
electromagnetically controlled stereotaxic impact device and injury
severity-dependent activation of a reporter gene. (A) A mouse in the
stereotaxic frame with the stereotaxic electromagnetic impactor aligned
above the head [(A), left panel] and with the impactor tip touching the surface
of the head [(A), middle panel]. The tip was fully extended and lowered at a
40° angle until it touched the head at the defined location (over the left
frontotemporal lobe) [(A), right panel]. (B) An mTBI induces reporter gene
activation in GFAP-luc mice. Representative images show increased
bioluminescence signals over baseline in the head after injury (right panel), but
not in sham treated mice (left panel). (C) GFAP-luc mice (male, 2–3 months
old, body weight 25.63±3.74 g) were randomly assigned to receive a single
impact (shown by the arrow) at different speeds (3, 4, or 5 m/s respectively)
but identical distance and dwell time as above. Bioluminescence is expressed
as fold induction over baseline. n=5 mice/group. Mean±SD; *P <0.05;
**P < 0.01; two-way ANOVA and Bonferroni test. (D) GFAP-luc mice (female,
2–3 months old, body weight 20.45±2.13 g) were randomly assigned to
receive different number of impacts. The impact was induced at a speed of
4.0 m/s with a dwell time of 0.2 s. Bioluminescence as a function of astrocyte
activation was measured 24 h after last impact and expressed as fold
induction over baseline (measured 1 day before injury for each mouse). n=5
mice/group. Mean±SD; *P <0.05; **P <0.01; ANOVA and Bonferroni test.
(E) GFAP-luc mice (female, 2–3 months old, body weight 20.31±2.37 g)
were randomly assigned to receive three impacts (repetitive,
impact–impact–impact, once a day for 3 days, shown by the arrows),
one impact (single, sham–sham–impact), and one sham (sham,
sham–sham–sham) procedures. The impact was induced by moving down the
stereotaxic device 3.0 mm, at a speed of 4.0 m/s with a dwell time of 0.2 s.
Bioluminescence as a function of astrocyte activation was measured and
expressed as fold induction over baseline (measured 1 day before injury for
each mouse). n=5 mice/group. Mean±SD; *P < 0.05; **P <0.01; two-way
repeated measures ANOVA and Bonferroni test.
over 3 min. For bioluminescence quantification, a region of inter-
est was manually selected over the head and kept constant for
all experiments; the signal intensity was converted into photons
per seconds per square millimeter per steradian. For longitudinal
comparison of bioluminescence, baseline imaging was performed
24 h before impact injury and bioluminescence was expressed as
fold induction over baseline levels for each mouse.
SMART-HOMECAGE MONITORING
The Smart-Homecage, developed by AfaSci, Inc.1 (Redwood City,
CA, USA), is a home cage behavior monitoring system (29).
This system is composed of infrared (IR) matrices for activity,
1http://www.afasci.com/
position, and locomotion detection. A fresh cage was inserted
into the Smart-Homecage platform. The mouse was placed in
the cage and allowed to explore the cage for 5 min. Parameters
of exploratory behavior, such as travel distance and rearing were
calculated automatically by CageScore software.
ROTA-ROD TESTING
Mice were trained and tested on an accelerating Rota-Rod (Ugo
Basile North America Inc., Collegeville, PA, USA) for motor
strength and coordination. The test procedure was performed
according to the SOP developed by the EUMORPHIA consor-
tium2. There is no training period prior to the test phase as this
2http://empress.har.mrc.ac.uk/viewempress/pdf/ESLIM_010_001.pdf
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actually improves the reproducibility and strain ranking effects
across centers (30). The Rota-Rod was set to accelerate from 5 to
30 rpm during a test period of 5 min. Mice were tested three times
with an inter-trial interval of 20 min, and the latency to fall onto
the transducer platform was automatically recorded. The average
latency of the three trials was calculated for the analysis.
DIGIGAIT ANALYSIS
The DigiGait System (Mouse Specifics, Boston, MA, USA) is a
non-invasive method for quantitative comparison of gait dynam-
ics. Each mouse was placed on a transparent belt of a treadmill
enclosed by a plastic scaffold. The speed of the belt was set at
20 cm/s for all mice. The mouse was imaged ventrally by a high-
speed camera, which captured the dynamics of the paws and
corresponding limbs while walking on the belt. The stride length
and other spatial and temporal gait indices for each limb were
analyzed automatically with the DigiGait Imaging System.
ELEVATED ZERO MAZE TESTING
The elevated zero maze was used to test for unconditioned anxiety-
like behaviors (31). The maze is a circular platform (outer diameter
46 cm, width 5.5 cm) that was elevated 40 cm above the floor. It
consists of two walled (white Plexiglas) sectors separated by two
open sectors of equal length. Each test session was started by plac-
ing the mouse in one of the two open sectors facing a closed sector.
The mouse was allowed to freely explore for 5 min. Activity was
recorded using a video-camera placed above the maze and TopScan
software (Clever Sys., Inc., Reston, VA, USA). Total path traveled
in the different sectors, percent of time spent in the open and
closed sectors, and number of open sector entries were automati-
cally analyzed by TopScan software. The mouse was then returned
to its home cage and the maze was cleaned with a 70% ethanol
between animals.
RADIAL ARMWATER MAZE
Spatial learning and memory was assessed using the radial arm
water maze (RAWM) paradigm following the exact protocol
described previously (32). The goal arm location containing a
platform remained constant throughout the training and testing
phase, while the start arm was changed during each trial. On day
1 during the training phase, mice were trained for 15 trials, with
trials alternating between a visible and hidden platform. On days
2 and 3 during the testing phase, mice were tested for 15 trials
with a hidden platform. Entry into an incorrect arm was scored
as an error, and errors were averaged over training blocks (three
consecutive trials).
Y-MAZE
The Y-maze is made of solid white plastic and consisted of two
symmetrical arms and one longer arm at 120° angles (longer arm,
20.7 cm length× 12.7 cm height× 7.62 cm width; equal arms,
15.24 cm length× 12.7 cm height× 7.62 cm width) (33). At the
beginning of trials, mice were placed in the end of the longer arm
and allowed to freely explore the three arms for 5 min. Arm entry
was defined as having all four limbs inside an arm. The maze was
cleaned with 70% ethanol between animals and before the first
animal to eliminate traces of odor. The number of arm entries
and the number of triads were recorded in order to calculate the
alternation percentage, which was calculated by dividing the num-
ber of triads by the number of possible alternations multiplied by
100. A triad was defined as a set of consecutive arm entries (34).
CONTEXTUAL FEAR CONDITIONING
Contextual fear conditioning was performed following the pre-
viously published procedures (32) with minor modifications. In
this task, mice learned to associate the environmental context (fear
conditioning chamber) with an aversive stimulus (mild foot shock;
unconditioned stimulus, US) enabling testing for hippocampal-
dependent contextual fear conditioning. As contextual fear condi-
tioning is hippocampus and amygdala-dependent, the mild foot
shock was paired with a light and tone cue (conditioned stimulus,
CS) in order to also assess amygdala-dependent cued fear con-
ditioning. Conditioned fear was displayed as freezing behavior.
Specific training parameters are as follows: tone duration is 30 s;
sound level is 70 dB, 2 kHz; shock duration is 2 s; and intensity
is 0.6 mA. More specifically, on the first day of testing (training),
each mouse was placed in a fear conditioning chamber and allowed
to explore for 2 min before delivery of a 30-s tone (70 dB) end-
ing with a 2-s foot shock (0.6 mA). Two minutes later, a second
CS–US pair was delivered. Shocks were delivered through the grid
floor and were controlled by FreezeScan software (Clever Sys., Inc.,
Reston,VA, USA). On the second day, each mouse was placed in the
same fear conditioning chamber containing the same context as
the training day, but without administration of a CS or foot shock.
Freezing was analyzed for 1–3 min. To analyze cued freezing behav-
ior, the mice were placed in a new context 1 h later that contained
a different odor (3% acetic acid), cleaning solution, floor texture,
chamber walls, and shape. Animals were allowed to explore for
2 min before being re-exposed to the CS. Freezing was analyzed for
1–3 min. Freezing was measured using a FreezeScan video tracking
system and software (Clever Sys., Inc., Reston, VA, USA).
TISSUE PROCESSING
Mice were anesthetized with 400 mg/kg chloral hydrate (Sigma-
Aldrich) and transcardially perfused with 0.9% saline (22, 28).
Brains were removed and postfixed in phosphate-buffered 4%
paraformaldehyde, pH 7.4, at 4°C for 48 h and sectioned at
40µm with a sliding microtome 2010 (Leica, Allendale, NJ, USA).
The sections were collected serially in 12 tubes and stored in
cryoprotective medium (22, 28).
CRESYL VIOLET STAINING
Brain sections (every 12th section) were mounted on Superfrost
plus slides (Fisher Scientific, Pittsburgh, PA, USA), air-dried, rehy-
drated, stained with 0.02% Cresyl Violet (Sigma) in acetate buffer
(pH 3.2), then dehydrated through a series of alcohols, cleared in
xylene, and coverslipped (28). Neuronal damage/loss was assessed
based on the appearance of gaps or thinning and disappearance
of the Nissl substance in the CA1 and CA3 pyramidal cell layers.
The lesion area was quantified with MetaMorph Imaging software
(Molecular Devices, Downingtown, PA, USA).
IMMUNOHISTOCHEMISTRY, LIGHT MICROSCOPY, AND IMAGE
ANALYSIS
Immunohistochemistry was performed on free-floating sections
(every 12th section) following standard procedures (22, 28).
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Primary antibodies were against: cleaved caspase-3 (1:1000, Cell
Signaling Technology, Danvers, MA, USA), GFAP (1:1000, Dako,
Carpinteria, CA, USA) (35), p-Tau (Ser202/Thr205, AT8) (1:1000,
Pierce, Rockford, IL, USA) (36), and p-CREB (Ser 133) (1:1000,
Millipore, Billerica, MA, USA) (37). After overnight incubation,
primary antibody staining was revealed using biotinylated sec-
ondary antibodies and the ABC kit (Vector, Burlingame, CA, USA)
with Diaminobenzidine (DAB, Sigma-Aldrich). Photographs were
acquired using a BX51 microscope (Olympus) and a SPOT Flex
shifting pixel CCD camera with SPOT Advanced software (SPOT
Imaging Solutions, Sterling Heights, MI, USA) under identical
conditions and settings. The immunoreactivity was quantified
as the percent area covered by ImageJ software (NIH, Bethesda,
MD, USA). Our initial observations revealed pathological changes
mainly from 0.98 to −2.06 mm to Bregma, and we therefore
restricted our quantification to sections covering that region. This
resulted typically in six and seven sections separated roughly by
12µm× 40µm, with half of the sections containing hippocam-
pus. We therefore performed image analysis in five sections/animal
for cortex and corpus callosum, and three sections/mouse for hip-
pocampus. The images were first converted to eight-bit gray-scale
images and then converted into binary positive/negative images by
thresholding held constant for all images in a given brain region.
Percent area fraction covered by the threshold was determined
by ImageJ. The average of values obtained from the three or five
sections was used for each animal for statistical analysis.
DATA ANALYSIS
Data are presented as mean± SD or mean± SEM depending on
the type of experiment. Statistical analysis of behavioral mea-
surements was performed with GraphPad Prism software (version
6) using ANOVA (regular or repeated measures) and Bonferroni
post hoc test or two-tailed Student’s t -test where appropriate.
P < 0.05 was considered statistically significant.
RESULTS
In this study, we carried out two series of experiments: the first to
investigate injury (impact intensity)-dependent responses in the
GFAP-luc reporter mice (FVB/N genetic background) to establish
injury parameters, and the second to investigate the behavioral
and pathological outcome of repetitive closed-head concussive
brain injury based on the above parameters in wild-type C57BL/6J
mice.
A MOUSE MODEL OF REPETITIVE CLOSED-HEAD mTBI
In the first series of experiments we employed bioluminescence
imaging, which enables us to follow astrogliosis and neural injury
in the reporter mice expressing luciferase under the control of a
GFAP promoter (GFAP-luc mice) (on FVB/N genetic background)
(22, 23). Neuronal injury is closely tied to astrogliosis, and we
and others have previously shown that bioluminescence inten-
sity in the GFAP-luc mice correlates significantly with astrogliosis
assessed by immunohistochemistry and with neural injury in brain
injury models of excitotoxicity and experimental autoimmune
encephalomyelitis (22, 23). In this study, we utilized this tech-
nique to take advantage of testing a relatively large number of
injury conditions in a medium-throughput manner while study-
ing the same mouse throughout the course of injury. In an initial
experiment, a mild traumatic impact (impact speed: 4 m/s) to the
head led to a reproducible, significant increase in bioluminescence
in the brain (Figure 1B). Notably, no significant increase in biolu-
minescence was observed after a sham procedure, suggesting that
the sham procedure caused negligible disturbance to the brain.
To determine whether different degrees of injury cause different
induction of bioluminescence signal,we impacted mice at different
impact speeds (3, 4, and 5 m/s, respectively) and observed a dose-
dependent increase of the bioluminescence signal (Figure 1C). To
determine whether repetitive injury is cumulative, we compared
the bioluminescence signals in mice receiving different numbers
of impacts (impact speed: 4 m/s; interval: approximately 24 h)
(Figure 1D). Twenty-four hours after the last impact, there was a
significant increase in bioluminescence signal in all injury groups
compared with the sham group. There appeared to be a dose-
dependent increase in bioluminescence signals in mice receiving
one to three impacts, but mice receiving five impacts did not
show further increase in bioluminescence signals compared with
those receiving three impacts (Figure 1D). We then compared
the time course of bioluminescence signals in mice receiving a
single impact with those receiving three impacts (Figure 1E). In
the single-impact group, bioluminescence signals increased sig-
nificantly at 24 h after impact (P < 0.05, compared with baseline),
but deceased significantly at day 3 (P > 0.05, compared with base-
line), and returned to pre-injury levels at day 7. The repetitive
group showed significantly higher bioluminescence signals at 24 h
after the third impact than the single-impact group (P < 0.01,
compared with baseline and with the single-impact group). While
the bioluminescence signals in the repeat-impact group decreased
to the same degree as in the single group at day 3, they were signif-
icantly higher overall (P < 0.01, compared with baseline and with
the single-impact group). At days 7 and 14, the bioluminescence
signals in the repeat-impact group were higher than baseline and
the single-impact group, but did not reach statistical significance
(P > 0.05).
To determine whether mTBI in our model causes motor
deficits, we performed Rota-Rod test. There was no significant dif-
ference between injured (one or three impacts) and sham groups
(Figure 2A). To determine whether mTBI causes long-term cog-
nitive deficits, we performed a fear conditioning test 3 months
after injury (Figure 2B). During fear conditioning training, mTBI
mice receiving three impacts exhibited reduced baseline freez-
ing time (Figure 2C). Importantly, mTBI mice receiving three
impacts demonstrated decreased freezing time during both cued
and contextual memory testing compared with sham animals
(P < 0.05). In contrast, mTBI mice receiving one impact did
not differ significantly from sham mice in freezing behavior at
baseline, nor did they differ significantly in cued or contextual
memory (Figure 2C). Thus, repetitive mTBI in our close-head
model produces consistent mild injuries, leading to long-term
memory, and cognitive deficits. In addition, correlation analysis
shows that bioluminescence signal in the GFAP-luc mice neg-
atively correlates with freezing behavior in the fear condition-
ing test (R=−0.704, P = 0.012) and with post-mortem p-CREB
immunoreactivity (R=−0.744, P = 0.007), suggesting that biolu-
minescence signal can be used as a surrogate marker in our mTBI
paradigm.
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FIGURE 2 | Repetitive mTBI causes significant cognitive impairments
3 months after injury. Three months after injury, the GFAP-luc mice shown
in Figure 1E were tested for motor function using a Rota-Rod apparatus (A)
and for learning and memory using fear conditioning (B,C). (A) In the
Rota-Rod test, latency to fall onto the transducer platform was automatically
recorded. The average latency over the three trials was calculated for each
mouse. No difference between the mTBI and sham groups were observed
(mean±SD, P >0.05 by t test). (B) The test paradigm for fear conditioning.
(C) The freezing behavior was recorded and analyzed. Mice exposed to
mTBI (three impacts) showed reduced baseline freezing behavior, and
context- and cue-related freezing behavior. n=5 mice/group. Mean±SD;
*P < 0.05, **P <0.01; ANOVA and Bonferroni test.
REPETITIVE CLOSED-HEAD mTBI CAUSED COGNITIVE DEFICITS
6MONTHS AFTER INJURY IN WILD-TYPE C57BL/6J MICE
Based on the results of astrogliosis and the behavioral deficits
observed in the reporter mice, the following injury parameters
were selected: impact speed: 4 m/s; number of impacts: 3; and
injury interval: 24 h. We induced repetitive mild brain injury and
characterized the outcome in wild-type C57BL/6J mice, a mouse
line more suitable for behavioral characterization and more com-
monly used in the field. We employed a battery of behavioral
tests (Figure 3A) and performed post-mortem histopathological
analysis to investigate whether the repetitive mTBI in our model
is capable of producing impairments similar to what is observed
in human mTBI patients.
INCREASED EXPLORATORY BEHAVIOR BASED ON HOMECAGE
MONITORING
At weeks 1 and 2, mTBI mice showed significantly increased
exploratory behavior during the first 5 min in a new environ-
ment, shown by increased travel distance and rearing behavior
(Figures 3C,D). However, no significant difference was found at
6 weeks after injury, suggesting that this effect recovered. In addi-
tion, there was no difference in either travel distance or rearing
behavior over 60-min monitoring (not shown), suggesting mTBI
did not cause significant motor deficits.
NO SIGNIFICANT MOTOR DEFICITS AFTER REPETITIVE mTBI
Absence of significant motor deficits in these mice was further
confirmed using Rota-Rod (Figure 3B), and the DigiGait analysis
system (Mouse Specifics, Inc.), which offers an automated analy-
sis of a large number of gait parameters. There was no consistent
difference between sham and mTBI mice in any of the parameters
measured, including stride length, stride width, stride frequency,
and stride length variability (Table 1).
NO ANXIETY-LIKE BEHAVIOR IN THE ELEVATED ZERO MAZE TESTS
To investigate whether mTBI mice show anxiety-like behavior we
employed an elevated zero maze test (31) and observed no dif-
ferences between mTBI and sham groups. Specifically, the mTBI
mice spent similar amounts of time in the closed arms of the maze
(Figure 4A). In addition, the number of bouts and the distance
moved in the entire maze were not significantly different between
the two groups (Figures 4B,C). Thus, mTBI mice did not display
unconditioned anxiety-like behaviors.
IMPAIRED SPATIAL LEARNING AND MEMORY 2 MONTHS AFTER
REPETITIVE mTBI
To determine whether the repetitive mTBI in our model led to cog-
nitive impairments in mice we assessed hippocampal-dependent
learning and memory using the RAWM paradigm (2 months after
injury). All mice showed similar spatial learning capacity during
the training phase regardless of treatment. However, by the end
of the testing phase animals exposed to repetitive mTBI exhibited
impaired learning and memory deficits, committing significantly
more errors in locating the target platform than sham animals
(Figure 5).
CUED AND CONTEXTUAL MEMORY DEFICITS 6 MONTHS AFTER
REPETITIVE mTBI
To determine whether the repetitive mTBI in our model led to cog-
nitive impairments at a later time point, we performed Y-maze and
contextual fear conditioning tests at 6 months after injury. There
was no difference in spontaneous alternation in the Y-maze test
(Figure 6A). In the fear conditioning test, both the sham and mTBI
animals exhibited similar baseline freezing behavior during train-
ing (Figure 6B). However, the mTBI group performed significantly
worse in the contextual test than the sham group (Figure 6B), as
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FIGURE 3 | Increased exploratory behavior after repetitive mTBI without
significant motor defects. Wild-type C57BL/6J mice (male, 3 months of age,
body weight 24.14±3.18 g) received three mild impacts (mTBI) or underwent
sham procedures (sham). (A) Schematic showing schedule of behavioral tests
employed in this study at the following time points after injury: SmartCage
(SC) and Rota-Rod (RR), 1, 2, and 6 weeks; Elevated zero maze (O maze),
6 weeks; radial arm water maze (RAWM), 7–8 weeks; and Y-maze and fear
conditioning (FC) 23–24 weeks. (B) Motor function was tested by a Rota-Rod
apparatus. No difference between the mTBI and sham groups was observed
at any time points. (C,D) Exploratory behavior was monitored for 5 min in the
SmartCage. Mice exposed to mTBI traveled significantly longer distance (C)
and reared significantly more (D) than the sham group at 1 and 2 weeks after
injury. n=8 (sham) and 15 (mTBI) mice/group. Mean±SD; *P <0.05,
repeated measures ANOVA.
shown by the significantly decreased freezing behavior. In addi-
tion, the mTBI group showed decreased freezing behavior in cued
memory retrieval detected 24 h after training when re-exposed to
the CS (tone and light) in a novel context (Figure 6B). Results from
contextual and cued periods were consistent with our observations
in FVB/N mice (Figure 2). Together, these data demonstrate that
repetitive mTBI impairs learning and memory as long as 6 months
after injury in our model.
PROMINENT PATHOLOGICAL ALTERATIONS AFTER REPETITIVE mTBI
To determine if the observed behavioral deficits are associated
with pathological changes (6 months after injury), we performed
post-mortem pathological examinations. We first performed
cresyl violet staining and did not observe contusions or obvious
cell loss (for example,percent area covered was 76.97± 4.53 in CA3
in mTBI and 79.29± 5.46 in sham, mean± SEM, P = 0.757 by t
test). We then performed immunohistochemistry using antibodies
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Table 1 | Gait parameters 2 weeks after injury.
Left front Left hind Right front Right hind
Sham mTBI Sham mTBI Sham mTBI Sham mTBI
Swing (s) 0.111±0.005 0.122±0.004 0.110±0.002 0.107±0.004 0.115±0.007 0.117±0.003 0.097±0.004 0.106±0.003
% Swing/stride 38.16±1.07 39.51±0.98 35.59±0.93 35.23±1.44 39.74±0.09 38.81±0.72 35.29±1.05 35.67±0.86
Braking (s) 0.087±0.002 0.096±0.005 0.038±0.004 0.041±0.003 0.088±0.004 0.086±0.005 0.043±0.002 0.046±0.002
% Braking/stride 30.47±0.57 31.20±1.68 13.65±1.37 13.33±1.02 30.76±1.60 28.83±1.96 15.96±1.14 15.61±0.83
Propel (s) 0.092±0.009 0.091±0.005 0.144±0.009 0.158±0.007 0.085±0.005 0.098±0.006 0.135±0.009 0.145±0.004
% Propulsion/stride 31.37±1.99 29.26±1.83 50.76±2.16 52.426±1.28 29.53±0.87 32.37±1.86 48.76±1.53 48.72±0.87
Stance (s) 0.180±0.009 0.186±0.003 0.181±0.007 0.198±0.007 0.173±0.006 0.185±0.003 0.178±0.007 0.192±0.005
% Stance/stride 61.4±1.073 60.49±0.083 64.41±0.093 64.77±1.44 60.26±0.090 61.19±0.72 64.71±1.05 64.33±0.86
Stride length (cm) 5.80±0.23 6.17±0.11 5.63±0.16 6.11±0.15 5.74±0.25 6.03±0.08 5.53±0.21 5.95±0.15
Stride (s) 0.290±0.011 0.309±0.005 0.281±0.008 0.305±0.007 0.288±0.012 0.302±0.004 0.276±0.010 0.298±0.007
Stance width (cm) 1.70±0.06 1.67±0.04 2.56±0.07 2.49±0.04 NA NA NA NA
Stance/swing (ratio) 1.66±0.08 1.56±0.07 1.81±0.07 1.89±0.12 1.53±0.05 1.59±0.05 1.84±0.08 1.82±0.07
FIGURE 4 | No significant difference was observed in the zero
maze test 6 weeks after repetitive brain injury. Wild-type
C57BL/6J mice (male, 3 months of age) received three mild impacts
(mTBI) or underwent sham procedures (sham), and were assessed
for anxiety using the elevated zero maze. The results were
expressed as time spent in the closed segment (A), number of
bouts (B), and travel distance (C). n=8 (sham) and 15 (mTBI)
mice/group. Mean±SD.
against cleaved caspase-3 (marker of apoptotic cell death, but we
observed only a few caspase-3 positive cells/section after mTBI,
which was not significantly different from that of sham), GFAP (a
marker of astrogliosis), p-Tau (a marker of impaired axonal trans-
port and axonal damage), and p-CREB [a marker of activation
of cAMP responsive element binding protein (CREB) pathway
related to memory formation and retention].
STRONG ASTROGLIOSIS AFTER REPETITIVE mTBI
In mice exposed to the repeat-impact mTBI, there was promi-
nent astrogliosis throughout the brain. Astrocytes showed mor-
phological characteristics of activation, including hypertrophic
appearances with thick, densely labeled processes, and large cell
bodies (Figure 7). Semi-quantitative estimation revealed that the
GFAP immunoreactivity was significantly increased in the ipsilat-
eral cortex (under the impact), hippocampus (CA3 region), and
corpus callosum in the mTBI group compared with the sham
group (Figure 7).
AXONAL DEGENERATION AFTER REPETITIVE mTBI
In sham treated mice, weak p-Tau immunoreactivity was observed
in a few, scattered cells in the brain; in contrast, stronger
p-Tau immunoreactivity was observed consistently from 0.74
to −1.82 mm to Bregma (26) (Figure 8A), in regions includ-
ing the ipsilateral corpus callosum, cortex, hippocampus, septal
nucleus, and amygdala (Figure 8B). In addition, weaker p-Tau
immunoreactivity was also observed in the contralateral side
(Figure 8A).
REDUCED p-CREB IMMUNOREACTIVITY AFTER REPETITIVE mTBI
To identify the potential molecular mechanisms responsible for
the observed cognitive deficits, we examined the activation of
CREB signaling. The CREB signaling pathway plays a critical
role in neuronal survival and in memory formation and cogni-
tive function (38, 39). Previous studies have shown this path-
way is altered in moderate to severe TBI (40, 41), but its role
in mTBI has not been investigated. We therefore performed
immunohistochemistry and compared p-CREB immunoreactiv-
ity in both mTBI and sham brains. There was a significant
reduction of p-CREB immunoreactivity in the hippocampus
(CA3 neurons) and amygdala (the central nucleus, CeA) of the
mice receiving mTBI compared with sham animals (Figure 9),
suggesting the CREB signaling pathway is compromised after
mTBI.
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FIGURE 5 | Repetitive mTBI causes significant cognitive impairments
2 months after injury. Wild-type C57BL/6J mice (male, 3 months of age)
received three mild impacts (mTBI) or underwent sham procedures (sham).
Spatial learning and memory was assessed using the radial arm water
maze (RAWM) paradigm 2 months after injury. On day 1 during the training
phase, mice are trained for 15 trials, with trials alternating between visible
and hidden platforms. On day 2 during the testing phase, mice are tested
for 15 trials with a hidden platform. Entry into an incorrect arm is scored as
an error, and the errors are averaged over training blocks (three consecutive
trials). Learning and memory deficits were quantified as the number of
entry arm errors made prior to finding the target platform. n= 8 (sham) and
15 (mTBI) mice/group. Mean±SEM; *P <0.05, repeated measures
ANOVA.
DISCUSSION
In this study, we have developed and characterized a mouse
model of repetitive mTBI using an electromagnetic stereotaxic
impact device. We show that animals subjected to three repetitive
mTBI with an inter-impact interval of 24 h displayed long-term
(6 months after injury) cognitive impairment, accompanied by
prominent pathological changes. These results demonstrate that
repetitive mTBI in mice leads to long-term consequences that
resemble those reported in people with repeat exposure to mTBI
and CTE.
A major challenge for developing experimental models of mTBI
is to replicate the long-term cognitive dysfunction, an impor-
tant feature of human mTBI patients (20). Although most pub-
lished mTBI models have demonstrated the ability to produce
immediate or short-term behavioral deficits, how long the cogni-
tive dysfunction lasts is unknown, since few studies made long-
term observations (beyond 1 month) (17, 18). In this study, we
employed two frequently used cognitive tests and demonstrated
that animals subjected to repetitive mTBI displayed cognitive
deficits at 2 (RAWM) and 6 months after injury (contextual fear
conditioning).
Cognitive deficits are a common problem seen in patients with
repetitive mTBI (21). The hippocampus is an important brain
region involved in learning and memory and is susceptible to
mild head injury (21). In our model, the repetitively injured mice
displayed behavioral deficits in hippocampus-dependent learning
paradigms such as RAWM and contextual and cued fear condition-
ing (33), suggesting that hippocampal function is compromised
in the mice in our model. The impacts in our model were applied
to the temporal side of the mouse head and thus probably caused
damage in the hippocampus and the cortex. The behavioral deficits
were observed only in repetitively injured mice that received three
impacts but not in the mice that received only a single impact,
suggesting that long-term behavior deficits are attributed to the
accumulative effects of multiple impacts.
Interestingly, mice exposed to repeated head impacts in
our model showed a transient increase in locomotor activity
(Figure 3). This is in agreement with observations from ath-
letes who have experienced repeated mild concussive injuries, and
often develop secondary problems with attention. These atten-
tion deficits are associated with hyperactivity (42). Hyperactivity
has been observed after repetitive mTBI in mice in a weight drop
model (43), suggesting that the increased locomotor activity is a
common feature after mTBI and provides additional validation of
our model.
Pathologically, we observed several changes following repeti-
tive mTBI injury in our model: (1) the absence of gross mor-
phological damage to the brain or obvious loss of neural tissue
beneath the point of impacts. (2) Mice subjected to repetitive
mTBI show prominent astrogliosis, as shown by increased GFAP
immunostaining. (3) Perhaps of greatest interest is the increased
immunoreactivity of p-Tau 6 months after the last injury. Tau
is an intracellular, microtubule-associated protein that is highly
enriched in axons. Hyperphosphorylation and pathological aggre-
gation of Tau is indicative of axonal injury and a common feature
of many neurodegenerative diseases with axonal degeneration.
Therefore these observations provide strong evidence of trau-
matic axonal injury in our model, supporting the hypothesis that
traumatic axonal injury is the primary pathology associated with
adverse outcomes following mTBI (44). Furthermore, we consis-
tently observed pathological changes in the hippocampus. This is
not only in agreement with the results of behavioral tests, but also
supports the notion that the hippocampus is especially vulnera-
ble to mTBI. In addition, increased p-Tau immunoreactivity and
astrogliosis could be pathological signs of CTE (45).
Mice receiving repetitive mTBI displayed reduced phosphory-
lation of CREB in the hippocampus. Since the CREB signaling
pathway has been implicated in promoting the neuronal survival
and in memory formation and cognitive function (38, 39), the
reduction of CREB signaling may explain at least part of the robust
cognitive deficits observed in behavioral tests in our model. Inter-
estingly, the activation of the CREB pathway follows a bi-phasic
pattern after TBI. In a fluid-percussion model producing a mod-
erate TBI, CREB was activated at 30 min, peaked at 24 h, and
returned to control level at 72 h after injury in the hippocampus
(41). CREB signaling remained unchanged at 2 or 8 weeks post-
injury, but was significantly decreased at 12 weeks after injury (40).
How mTBI leads to reduced CREB signaling needs further inves-
tigation. Secondary injury mechanisms such as oxidative stress
and excitotoxicity are both known to inhibit CREB phosphoryla-
tion and thus may play a role. It is also noteworthy that reduced
immunoreactivity of p-CREB was observed in the absence of
significant gross structural damage or neuronal cell loss, suggest-
ing that compromised neuronal integrity may underlie long-term
behavioral deficits.
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FIGURE 6 | Repetitive mTBI causes significant cognitive
impairments 6 months after injury. Wild-type C57BL/6J mice (male,
3 months of age) received three mild impacts (mTBI) or underwent
sham procedures (sham). Cognitive function was assessed using the
Y-maze (A) and contextual fear conditioning (B) 6 months after injury.
(A) In the Y-maze test for working memory, there was no difference in
spontaneous alternations between mTBI and sham mice. (B) In the
fear conditioning test, no significant statistical difference was apparent
in baseline freezing, however, mTBI mice showed significantly
impaired context and cued memory compared with sham animals.
n= 8 (sham) and 15 (mTBI) mice/group. Mean±SD. *P <0.05;
by t test.
FIGURE 7 | Significant astrogliosis after repetitive mTBI. Wild-type
C57BL/6J mice (male, 3 months of age) received three mild impacts (mTBI)
or underwent sham procedures (sham). Mice were sacrificed 6 months
later and brains were fixed for immunohistochemistry with an antibody
against GFAP. Representative images were taken from cortex (A),
hippocampus (C), and corpus callosum (E), and GFAP immunoreactivity
(B,D,F) was quantified as percentage of area occupied. Scale bar in
(A,C)=20µm. Insert in (A,C) shows a high-magnification view of an
astrocyte (arrow). n= 8 (sham) and 15 (mTBI) mice/group. Mean±SEM.
*P <0.05; **P < 0.01, by t test.
GFAP is an extensively studied TBI biomarker and serum
GFAP concentration is found to be predictive of death or
poor outcome (46). Therefore, in this study we utilized a
bioluminescence in vivo imaging technique in GFAP reporter
mice. We have previously shown that the bioluminescence sig-
nal in the GFAP-luc mice correlates significantly with astroglio-
sis assessed by immunohistochemistry and bioluminescence
imaging of these reporter mice is more sensitive in detecting
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FIGURE 8 | Prominent p-Tau immunoreactivity after repetitive mTBI.
Wild-type C57BL/6J mice (male, 3 months of age) received three mild
impacts (mTBI) or underwent sham procedures (sham). Mice were
sacrificed 6 months later and brains were fixed for immunohistochemistry
with an antibody against phospho-Tau (p-Tau, AT8). (A) Schematic diagrams
of brain sections adapted from the mouse brain atlas (26) represent the
approximate antero-posterior levels (to Bregma) where consistent
neuropathological alterations were observed in mTBI (bottom) compared
with sham (top). Note less p-Tau immunopositive cells in the contralateral
side. The arrows in the bottom panel show approximate point of impact.
(B) Representative images obtained from ipsilateral side of mTBI showing
p-Tau immunoreactive cells in the corpus callosum, amygdala, hippocampus,
and septal nuclei. Notice the weak or absence of p-Tau immunoreactivity in
sham group. Scale bar= 20µm.
astrogliosis than immunohistochemistry in a model of autoim-
mune encephalomyelitis (22, 23). We show here that the GFAP-luc
reporter gene is also responsive to mTBI and can be used to
monitor the initial astroglial response to mild brain injury and
maybe more importantly, could be used to monitor the efficacy of
experimental treatments for mTBI.
In our model the impact is delivered non-invasively and directly
to the mouse head, without surgical intrusions. Our choice of
the impact force (4 m/s) produces no skull fracture, nor external
damage to the brain tissue. In addition, the impacts do not induce
significant motor deficits or anxiety, indicating the injury did not
affect the animals’ well being and thus allows a reliable assess-
ment of the cognitive consequences of repetitive impacts to the
brain (47). Our setup allows for accurate delivery of repetitive mild
injuries to the same subject. The procedure is simple and rapid and
can be performed without craniotomy or other manipulations to
the head or skull. Thus our model is suitable for medium- to high-
throughput screening of therapeutic compounds in a closed head,
mild brain trauma.
In conclusion, we have developed a mouse model of repetitive
mTBI with long-term behavioral and pathological sequelae, which
resemble those observed in human mTBI patients. The model
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FIGURE 9 | cAMP responsive element binding protein
phosphorylation was significant reduced after repetitive mTBI.
Wild-type C57BL/6J mice (male, 3 months of age) received three mild
impacts (mTBI) or underwent sham procedures (sham). Mice were
sacrificed 6 months later and brains were fixed for immunohistochemistry
with an antibody against p-CREB. Representative images were taken
from amygdala (A) and hippocampus (C), and p-CREB immunoreactivity
(B,D) was quantified as percentage of area occupied. Scale bar in
(A,C)=20µm. n=8 (sham) and 15 (mTBI) mice/group. Mean±SEM.
*P <0.05, by t test.
can be used to study the long-term neurological and pathological
consequences of different numbers and frequencies of mild head
injuries, and the molecular mechanisms of repetitive concussive
injury to the brain. Our model may also be suitable for evaluating
potential therapeutic interventions for mTBI.
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